Posted by Michael Wonder on 22 Jun 2026
Australia’s drug approval system faces reckoning as patients await reform
22 June 2026 - Health Minister Mark Butler has tied long-overdue drug pricing reforms to July negotiations with pharma, leaving Australia’s medicines approval system under pressure.
Australia’s decision to delay overhauling the nation’s drug assessment systems is piling pressure on the independent committee that approves medicines for public subsidy as pharmaceutical giants ramp up their criticisms of Australia’s slow processes and drug pricing.
